The Food and Drug Administration Friday issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. Among other recommendations, FDA recommends providers carefully follow the stapler manufacturer’s instructions for use, have a range of staple sizes available and select the appropriate size cartridge for the tissue. Since 2011, the agency has received more than 41,000 medical device reports for surgical staplers and staples for internal use, including 366 deaths. FDA plans this year to issue draft guidance to manufacturers on information to include in their product labeling and to hold a public meeting on whether to reclassify the staplers as Class II devices, which would allow the agency to establish mandatory special controls to mitigate known risks.

Related News Articles

Headline
About half of U.S. health care workers have witnessed racial discrimination against patients and say discrimination against patients is a crisis or major…
Chairperson's File
The mission of all hospitals and health systems, regardless of size and location, is to provide quality care to patients and advance health in their…
Headline
The Centers for Disease Control and Prevention has released a five-part webinar series on its Hospital Sepsis Program Core Elements, which offer guidance to…
Headline
The AHA CLEAR Crisis Leadership Video Series, now available on demand, features hospital and health system leaders sharing insights, strategies and lessons…
Blog
Happy New Year to all! It’s exciting to experience the shift in the calendar because it’s an opportunity for us to look with optimism at what is to come.…
Headline
In updated guidance for makers of medical devices labeled as sterile, the Food and Drug Administration Jan. 8 listed vaporized hydrogen peroxide as an…